Fate Therapeutics (FATE) Debt Ratio (2012 - 2019)
Fate Therapeutics' (FATE) quarterly Debt Ratio came in at 0.04 in Q3 2019, down 39.4% YoY from 0.07 in Q3 2018, and down 45.12% on a QoQ basis from 0.07 in Q2 2019.
Fate Therapeutics (FATE) Debt Ratio (2012 - 2019) Analysis & Trends
Fate Therapeutics (FATE) has 8 years of Debt Ratio data on file, last reported at 0.04 in Q3 2019.
- Quarterly Debt Ratio fell 39.4% year-over-year to 0.04 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 0.04 (down 39.4% YoY) and the FY2018 annual result came in at 0.07, down 50.32% from the prior year.
- Debt Ratio fell to 0.04 in Q3 2019, from 0.07 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.44 in Q1 2015 to a low of 0.04 in Q3 2019.
- A 5-year average of 0.18 and a median of 0.18 in 2018 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2015 — Debt Ratio soared 1670.23% — and 2017, when it plunged 69.69%.
- Tracing FATE's Debt Ratio over 5 years: stood at 0.27 in 2015, then slumped by 58.42% to 0.11 in 2016, then increased by 25.07% to 0.14 in 2017, then tumbled by 50.32% to 0.07 in 2018, then sank by 41.39% to 0.04 in 2019.
- The last three Debt Ratio figures came in at 0.04 (Q3 2019), 0.07 (Q2 2019), and 0.07 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 0.04 |
| Jun 30, 2019 | 0.07 |
| Mar 31, 2019 | 0.07 |
| Dec 31, 2018 | 0.07 |
| Sep 30, 2018 | 0.07 |
| Jun 30, 2018 | 0.18 |
| Mar 31, 2018 | 0.16 |
| Dec 31, 2017 | 0.14 |
| Sep 30, 2017 | 0.20 |
| Jun 30, 2017 | 0.09 |
| Mar 31, 2017 | 0.19 |
| Dec 31, 2016 | 0.11 |
| Sep 30, 2016 | 0.26 |
| Jun 30, 2016 | 0.30 |
| Mar 31, 2016 | 0.28 |
| Dec 31, 2015 | 0.27 |
| Sep 30, 2015 | 0.25 |
| Jun 30, 2015 | 0.24 |
| Mar 31, 2015 | 0.44 |
| Dec 31, 2014 | 0.38 |